In line with our on-going commitment to providing quality training and promoting the highest safety standard, Richmond Pharmacology are pleased to announce that our ILS Courses are now open to the public. In association with the Resuscitation Council UK, Richmond Pharmacology’s highly trained Resuscitation and Clinical Skills Practitioners will equip external healthcare professionals with the skills to assist patients in preventing or treating cardiac arrest.

To register your interest, or to find out more about the training offered by Richmond Pharmacology, please click here.Additionally, to find out more about the ILS training courses offered by the Resuscitation Council (UK), please check here.

Latest news

Von Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

First patient enrolled in telehealth study, the Pathway Study

February 25, 2025
The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event